Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 3/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CDC25B | P30305 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | MYC | P01106 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.42 |
| ▸ | CDC25A | P30304 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13183116 | 0.81 | AKR1C3 (0.61) | AKR1C3GAAMAPTTSHRALDH1A1 | |
| SCHEMBL17712467 | 0.80 | CES2 (0.39) | AKR1C3GAAMAPTTSHRALDH1A1 | |
| SCHEMBL9725154 | 0.80 | CES2 (0.50) | MAPTTSHRALDH1A1POLBHPGD | |
| SCHEMBL700595 | 0.79 | AKR1C3 (0.85) | AKR1C3GAAMAPTTSHRALDH1A1 | |
| SCHEMBL29447165 | 0.79 | AKR1C3 (0.85) | AKR1C3GAAMAPTTSHRALDH1A1 | |
| SCHEMBL3305342 | 0.79 | AKR1C3 (0.59) | AKR1C3GAAMAPTTSHRALDH1A1 | |
| SCHEMBL822891 | 0.78 | AKR1C3 (0.68) | AKR1C3GAAMAPTALDH1A1CDC25B | |
| SCHEMBL28883310 | 0.77 | AKR1C3 (0.81) | AKR1C3GAAMAPTALDH1A1CDC25B | |
| Fluoride SCHEMBL28319246 | 0.77 | AKR1C3 (0.81) | AKR1C3GAAMAPTALDH1A1CDC25B | |
| SCHEMBL13159280 | 0.76 | HPGD (0.69) | AKR1C3GAAMAPTTSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4171602-A2 | CCR8 ANTIBODIES AND USES THEREOF | Bayer Aktiengesellschaft (DE) | 2023-05-03 | — | — | EP | disclosed |
| EP-4171601-A2 | SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION | Bayer Aktiengesellschaft (DE) | 2023-05-03 | — | — | EP | disclosed |
| EP-4172201-A2 | CHEMOKINE RECEPTOR ANTIBODIES BINDING SULFATED TRD MOTIFS | Bayer Aktiengesellschaft (DE) | 2023-05-03 | — | — | EP | disclosed |
| EP-4172204-A2 | CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS | Bayer Aktiengesellschaft (DE) | 2023-05-03 | — | — | EP | disclosed |
| EP-4172202-A2 | ANTI CCR8 ANTIBODY THERAPY: BIOMARKERS & COMBINATION THERAPIES | Bayer Aktiengesellschaft (DE) | 2023-05-03 | — | — | EP | disclosed |
| WO-2021260210-A2 | ANTI CCR8 ANTIBODY THERAPY: BIOMARKERS & COMBINATION THERAPIES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-12-30 | — | — | WO | disclosed |
| WO-2021260208-A2 | SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION | BAYER AKTIENGESELLSCHAFT (DE) | 2021-12-30 | — | — | WO | disclosed |
| WO-2021260206-A2 | CHEMOKINE RECEPTOR ANTIBODIES BINDING SULFATED TRD MOTIFS | BAYER AKTIENGESELLSCHAFT (DE) | 2021-12-30 | — | — | WO | disclosed |
| WO-2021260209-A2 | CCR8 ANTIBODIES AND USES THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 2021-12-30 | — | — | WO | disclosed |
| WO-2021152186-A2 | CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2021-08-05 | — | — | WO | disclosed |
| EP-3383909-A1 | ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE | AbbVie Inc. (US) | 2018-10-10 | — | — | EP | disclosed |
| EP-3383910-A1 | ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE | AbbVie Inc. (US) | 2018-10-10 | — | — | EP | disclosed |
| WO-2017095808-A1 | ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE | ABBVIE INC. (US) | 2017-06-08 | — | — | WO | disclosed |
| WO-2017095805-A1 | ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE | ABBVIE INC. (US) | 2017-06-08 | — | — | WO | disclosed |